Home
Conditions
Lymphoproliferative Disorders

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,079 public trials 2,046 recruiting studies

Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

Thalidomide for Multiple Myeloma

NCT00038233

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: University of Texas M. D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Thalidomide-Dexamethasone for Multiple Myeloma

NCT00038090

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: University of Texas M. D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Mass Balance, Pharmacokinetics and Metabolism Study of Alisertib

NCT01714947

Conditions: Advanced Solid Tumors, Hemic and Lymphatic Diseases, Immune System Diseases, +6 more
Locations: Comprehensive Clinical Development Tacoma, Washington, United States

View Trial Details

Completed

A Phase II Study of Paclitaxel and Topotecan With Filgrastim-SD/01 Support For Relapsed and Refractory Aggressive Non-Hodgkin's Lymphoma

NCT00038545

Conditions: Aberrant Motor Behavior in Dementia, Aggression, Behavior, +12 more
Locations: UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Bortezomib and Lenalidomide in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma

NCT00553644

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Kaiser Permanente-Anaheim Anaheim, California, United States

Kaiser Permanente-Baldwin Park Baldwin Park, California, United States

Kaiser Permanente-Bellflower Bellflower, California, United States

Kaiser Permanente-Fontana Fontana, California, United States

View all 82 locations

View Trial Details

Completed

Targeted BEACOPP Variants in Patients With Newly Diagnosed Advanced Classical Hodgkin Lymphoma

NCT01569204

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +7 more
Locations: 1st Dept. of Medicine, Cologne University Hospital Cologne, Germany

View Trial Details

Completed

Phase II Study Of Roferon and Accutane For Patients With T-Cell Malignancies

NCT00038376

Conditions: Hematologic Diseases, Hematologic Neoplasms, Hemic and Lymphatic Diseases, +12 more
Locations: M. D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

NCT00005092

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +77 more
Locations: University of Illinois at Chicago Chicago, Illinois, United States

Washington University Barnard Cancer Center St Louis, Missouri, United States

University of Texas - MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Dolastatin 10 in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia

NCT00003693

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +27 more
Locations: University of Texas - MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Bone Marrow Transplantation in Treating Patients With Chronic Lymphocytic Leukemia

NCT00002844

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +13 more
Locations: University of Texas - MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Lymphoproliferative Disorders

Lymphoproliferative Disorders trial results

Related conditions